2seventy Bio Stock Profit Margin
TSVT Stock | USD 4.60 0.04 0.88% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
Last Reported | Projected for Next Year | ||
Net Loss | (2.17) | (2.28) |
2Seventy | Profit Margin |
2Seventy Bio Company Profit Margin Analysis
2Seventy Bio's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current 2Seventy Bio Profit Margin | (2.17) % |
Most of 2Seventy Bio's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2Seventy Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
2Seventy Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for 2Seventy Bio is extremely important. It helps to project a fair market value of 2Seventy Stock properly, considering its historical fundamentals such as Profit Margin. Since 2Seventy Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 2Seventy Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 2Seventy Bio's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
2Seventy Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, 2Seventy Bio has a Profit Margin of -2.1673%. This is 80.67% lower than that of the Biotechnology sector and 90.59% lower than that of the Health Care industry. The profit margin for all United States stocks is 70.65% higher than that of the company.
2Seventy Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in profit margin category among related companies.
2Seventy Fundamentals
Return On Equity | -0.77 | ||||
Return On Asset | -0.22 | ||||
Profit Margin | (2.17) % | ||||
Operating Margin | (5.60) % | ||||
Current Valuation | 273.66 M | ||||
Shares Outstanding | 51.4 M | ||||
Shares Owned By Insiders | 2.50 % | ||||
Shares Owned By Institutions | 98.22 % | ||||
Number Of Shares Shorted | 6.48 M | ||||
Price To Book | 1.01 X | ||||
Price To Sales | 2.58 X | ||||
Revenue | 100.39 M | ||||
Gross Profit | (183.46 M) | ||||
EBITDA | (206.42 M) | ||||
Net Income | (217.57 M) | ||||
Cash And Equivalents | 357.93 M | ||||
Cash Per Share | 9.45 X | ||||
Total Debt | 256.67 M | ||||
Debt To Equity | 0.73 % | ||||
Current Ratio | 3.88 X | ||||
Book Value Per Share | 5.04 X | ||||
Cash Flow From Operations | (166.86 M) | ||||
Short Ratio | 4.06 X | ||||
Earnings Per Share | (4.42) X | ||||
Target Price | 11.0 | ||||
Number Of Employees | 274 | ||||
Beta | 1.85 | ||||
Market Capitalization | 234.41 M | ||||
Total Asset | 565.43 M | ||||
Retained Earnings | (511.22 M) | ||||
Working Capital | 177.99 M | ||||
Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether 2Seventy Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if 2Seventy Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about 2seventy Bio Stock. Highlighted below are key reports to facilitate an investment decision about 2seventy Bio Stock:Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Altman Z Score analysis. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.42) | Revenue Per Share 2.037 | Quarterly Revenue Growth (0.81) | Return On Assets (0.22) | Return On Equity (0.77) |
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.